Pseudogenes in Human Cancer
Open Access
- 25 September 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 2, 68
Abstract
Recent advances in the analysis of RNA-sequencing (RNA-seq) data have shown that pseudogenes are highly specific markers of cell identity and can be used as diagnostic and prognostic markers. Furthermore, genetically engineered mouse models have recently provided compelling support for a causal link between altered pseudogene expression and cancer. In this review, we discuss the most recent milestones reached in the pseudogene field and the use of pseudogenes as cancer classifiers.Keywords
Funding Information
- Istituto Toscano Tumori
- National Institutes of Health (RO1 CA082328, RO1 CA170158)
This publication has 57 references indexed in Scilit:
- Role of the ERas gene in gastric cancer cellsOncology Reports, 2013
- Transcribed pseudogene ψPPM1K generates endogenous siRNA to suppress oncogenic cell growth in hepatocellular carcinomaNucleic Acids Research, 2013
- Evidence for conserved post-transcriptional roles of unitary pseudogenes and for frequent bifunctionality of mRNAsGenome Biology, 2012
- Landscape of transcription in human cellsNature, 2012
- Expressed Pseudogenes in the Transcriptional Landscape of Human CancersCell, 2012
- Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis?Gynecologic Oncology, 2012
- Deletion of PTENP1 Pseudogene in Human MelanomaJournal of Investigative Dermatology, 2011
- The Melanoma-Upregulated Long Noncoding RNA SPRY4-IT1 Modulates Apoptosis and InvasionCancer Research, 2011
- microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancerOncogene, 2011
- A coding-independent function of gene and pseudogene mRNAs regulates tumour biologyNature, 2010